InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FDC +NVN | News: Federation Centres & Novion announce merger | 03/08/15 | 29 | 10K | |||
|
|||||||
NVN | News: Strategic investing in property stocks | 03/07/15 | 0 | 398 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Angus McNaughton | 12/06/15 | 0 | 255 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Trevor Gerber | 12/06/15 | 0 | 250 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Richard Haddock | 12/06/15 | 0 | 271 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Peter Kahan | 12/06/15 | 0 | 240 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Peter Hay | 12/06/15 | 0 | 286 | |||
|
|||||||
NVN | Ann: Final Director's Interest Notice - Nancy Milne | 12/06/15 | 0 | 317 | |||
|
See All Discussions